TARS Stock-Based Compensation
Tarsus Pharmaceuticals Inc · Stock-Based Compensation
TARS Stock-Based Compensation
Latest reported$51.81Mperiod ending
TARS TTM Stock-Based Comp ($13.50K → $51.81M)
TTM stock-based compensation
High-resolution chart · PNG
TARS stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 51,813,000 | |
| 46,757,000 | |
| 41,720,000 | |
| 34,809,000 | |
| 29,981,000 | |
| 29,229,000 | |
| 27,818,000 | |
| 25,897,000 | |
| 23,732,000 | |
| 21,443,000 | |
| 19,830,000 | |
| 18,019,000 | |
| 16,352,000 | |
| 14,692,000 | |
| 13,460,000 | |
| 11,968,000 | |
| 10,504,000 | |
| 9,766,000 | |
| 8,455,000 | |
| 6,714,000 | |
| 4,819,000 | |
| 2,198,000 | |
| 839,000 | |
| 406,000 | |
| 186,000 | |
| 15,250 | |
| 13,500 |